Home › Asset managers › Compare 2025-2026 › Equitable vs Prudential/PGIM
Equitable 2025-2026 · Prudential/PGIM 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 26,688 | 21,052 | 924 | 4,712 | 95.8% | 89.3% |
| Board proposals | 24,319 | 19,234 | 851 | 4,234 | 95.8% | 89.4% |
| E&S shareholder proposals | 196 | 96 | 3 | 97 | 97.0% | 82.8% |
| Other items | 2,173 | 1,722 | 70 | 381 | 96.1% | 88.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
5,636 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Equitable | Prudential/PGIM |
|---|---|---|---|---|---|---|
| AMTECH SYSTEMS, INC. | March 4, 2026 | Election of Directors: Michael M. Ludwig Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| AMTECH SYSTEMS, INC. | March 4, 2026 | To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AMYLYX PHARMACEUTICALS, INC. | June 4, 2026 | Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George Mclean Milne Jr., Ph.D. Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| ANHUI CONCH CEMENT CO LTD | May 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| ANZ GROUP HOLDINGS LIMITED | December 18, 2025 | Approve Remuneration Report Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| ARCBEST CORPORATION | April 24, 2026 | To approve the reincorporation of the Company to the State of Texas by conversion. Extraordinary Transactions |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ARCUS BIOSCIENCES, INC. | June 11, 2026 | To approve, on an advisory basis, the compensation of Arcus Biosciences' named executive officers, as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| ARQ, INC. | June 10, 2026 | To approve the Arq, Inc. 2026 Omnibus Incentive Plan; and Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ARRAY DIGITAL INFRASTRUCTURE, INC. | October 9, 2025 | Advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| ARRAY TECHNOLOGIES, INC. | May 19, 2026 | Approval, on an advisory basis, of our named executive officer compensation. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| ATEA PHARMACEUTICALS, INC. | June 18, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ATYR PHARMA, INC | May 11, 2026 | To approve an amendment to the aTyr Pharma, Inc. 2015 Stock Option and Incentive Plan, as amended: Compensation |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ATYR PHARMA, INC | May 11, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| ATYR PHARMA, INC | May 11, 2026 | To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors"), to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified; Eric Benevich Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| AUDIOEYE, INC. | June 22, 2026 | To approve, by non-binding advisory vote, the compensation of AudioEye, Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation Report of Corporate Officers Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation of Marc de Garidel, CEO Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Compensation of Sylvie Gregoire, Chairwoman of the Board Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 750,000 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Issuance of Equity or Equity-Linked Securities for Qualified Investors, up to Aggregate Nominal Amount of EUR 237,873.56 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Issuance of Warrants (Bons) Reserved for Services Providers, Consultants, Employees and Executives, up to 10 Percent of Issued Share Capital Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Remuneration Policy of CEO Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Approve Remuneration Policy of Chairwoman of the Board Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Capital Increase of Up to EUR 750,000 for Future Exchange Offers Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 750,000 Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize up to 10 Percent of Issued Capital for Use in Restricted Stock Plans Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Authorize up to 10 Percent of Issued Capital for Use in Stock Option Plans Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Reelect June Lee as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Reelect Sylvie Gregoire as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Abivax SA | May 11, 2026 | Reelect Troy Ignelzi as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Aclaris Therapeutics, Inc. | June 4, 2026 | Election of Directors: Maxine Gowen, Ph.D. Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: David Maher Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: Ho Yeon (Aaron) Lee Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Acushnet Holdings Corp. | June 8, 2026 | Election of the following nominees for director: Keun Chang (Kevin) Yoon Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Akebia Therapeutics, Inc. | June 17, 2026 | Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: Adrian Adams Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 1 fund |
| Aldeyra Therapeutics, Inc. | June 9, 2026 | Election of one Class III Director: Todd C. Brady, M.D., Ph.D. Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Daniel E. Coughlin Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Galen G. Vetter Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Janet O. Estep Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Jeffrey W. Bolton Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: John Uribe Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Katie A. Lorenson Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Mary E. Zimmer Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Nikki L. Sorum Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Alerus Financial Corporation | May 14, 2026 | Election of Directors: Randy L. Newman Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| Allianz SE | May 7, 2026 | Authority to Issue Convertible Debt Instruments; Increase in Conditional Capital Capital Structure |
Board | For | FOR 1 fund |
AGAINST 12 funds |
| Alphabet Inc. | June 5, 2026 | Election of Directors: John L. Hennessy Director Elections |
Board | For | AGAINST 1 fund |
FOR 34 funds |
| Alstom | July 10, 2025 | Authority to Issue Performance Shares Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| Amdocs Limited | January 30, 2026 | Election of Directors: Yvette Kanouff Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Amerant Bancorp Inc. | June 2, 2026 | To elect the directors to serve until the 2027 annual meeting of shareholders: Millar Wilson Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| Ameresco, Inc. | June 4, 2026 | To approve an amendment to Ameresco's 2020 Stock Incentive Plan ("Plan) to increase the number of shares of Ameresco, Inc. Class A Common Stock authorized for issuance under the Plan by 3,200,000 from 5,000,000 to 8,200,000 as described in the Ameresco, Inc. Proxy Statement. Compensation |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| AmeriServ Financial, Inc. | July 29, 2025 | An advisory vote to approve the compensation of the named executive officers of the Company (Matter No. 2); Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Amprius Technologies, Inc. | June 11, 2026 | Election of Class I Directors: Thomas M. Stepien Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Anheuser-Busch Inbev SA/NV | April 29, 2026 | Remuneration Policy Compensation |
Board | For | AGAINST 1 fund |
FOR 13 funds |
| Anheuser-Busch Inbev SA/NV | April 29, 2026 | Remuneration Report Compensation |
Board | For | AGAINST 1 fund |
FOR 13 funds |
| Annexon, Inc. | June 11, 2026 | To elect the two nominees for director to serve as Class III directors to hold office until the 2029 annual meeting of stockholders: Bettina M. Cockroft, M.D. Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| Antero Midstream Corporation | June 3, 2026 | Class I Nominees: Janine J. McArdle Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Antero Midstream Corporation | June 3, 2026 | Class I Nominees: Peter A. Dea Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Ardent Health, Inc. | May 20, 2026 | Election of Directors: Ellen Havdala Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| Asahi Group Holdings Ltd. | March 24, 2026 | Approve Allocation of Income, with a Final Dividend of JPY 26 Capital Structure |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| Ashtead Group plc | September 2, 2025 | Authority to Issue Shares w/o Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Ashtead Group plc | September 2, 2025 | Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Ashtead Group plc | September 2, 2025 | Elect Angus Cockburn Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| Assa Abloy AB | April 28, 2026 | Adoption of Share-Based Incentives (LTIP 2026) Compensation |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| Assa Abloy AB | April 28, 2026 | Election of Directors Director Elections |
Board | For | AGAINST 1 fund |
FOR 7 funds |
| AstraZeneca plc | April 9, 2026 | Authority to Issue Shares w/o Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 9 funds |
| AstraZeneca plc | April 9, 2026 | Authority to Issue Shares w/o Preemptive Rights (Specified Capital Investment) Capital Structure |
Board | For | FOR 1 fund |
AGAINST 9 funds |
| AstraZeneca plc | April 9, 2026 | Elect Rene Haas Director Elections |
Board | For | AGAINST 1 fund |
FOR 14 funds |
| AstraZeneca plc | April 9, 2026 | Elect Sherilyn S. McCoy Director Elections |
Board | For | FOR 1 fund |
AGAINST 9 funds |
| Atlas Copco AB | April 28, 2026 | Adoption of Share-Based Incentives (Personnel Option Plan 2026) Compensation |
Board | For | AGAINST 1 fund |
FOR 14 funds |
| Atlas Copco AB | April 28, 2026 | Elect Martin Lundstedt Director Elections |
Board | For | AGAINST 1 fund |
FOR 14 funds |
| Atlas Copco AB | April 28, 2026 | Elect Peter Wallenberg Jr. Director Elections |
Board | For | FOR 1 fund |
AGAINST 14 funds |
| Atlas Copco AB | April 28, 2026 | Elect Vagner Rego Director Elections |
Board | For | FOR 1 fund |
AGAINST 14 funds |
| Aviva plc | May 6, 2026 | Annual Bonus Plan Compensation |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| Aviva plc | May 6, 2026 | Authority to Issue Shares w/o Preemptive Rights Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| Azenta, Inc. | January 28, 2026 | Election of Directors: Martin Madaus Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| BAKKT, INC. | June 23, 2026 | Advisory Vote to Approve Executive Compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| BANK FIRST CORPORATION | June 15, 2026 | To elect three (3) directors of the Corporation, each for three-year terms and in each case until their successors are elected and qualified; STEVEN M. ELDRED Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| BARRICK MINING CORPORATION | May 8, 2026 | ADVISORY RESOLUTION ON APPROACH TO EXECUTIVE COMPENSATION. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| BAXTER INTERNATIONAL INC. | May 5, 2026 | Advisory Vote to Approve Named Executive Officer Compensation for 2025 Say-on-Pay |
Board | For | FOR 16 funds |
AGAINST 8 funds |
| BCB BANCORP, INC. | April 23, 2026 | Election of Directors: James Rizzo Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| BCB BANCORP, INC. | April 23, 2026 | Election of Directors: Michael Widmer Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| BCB BANCORP, INC. | April 23, 2026 | Election of Directors: Ryan Blake Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| BED BATH & BEYOND, INC. | May 14, 2026 | The approval, on an advisory (non-binding) basis, of the compensation paid by the Company to its named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| BELLRING BRANDS, INC. | January 28, 2026 | To consider and vote, on an advisory basis, for the adoption of a resolution approving the compensation of our named executive officers, as such compensation is described under the "Compensation Discussion and Analysis" and "Executive Compensation" sections of this proxy statement. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| BGC Group, Inc. | November 12, 2025 | Election of Directors: Brandon G. Lutnick Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| BGC Group, Inc. | November 12, 2025 | Election of Directors: Stephen M. Merkel Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| BGSF, Inc. | November 5, 2025 | Election of Directors: Paul A. Seid Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| BGSF, Inc. | November 5, 2025 | Election of Directors: Richard L. Baum, Jr. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| BIOMARIN PHARMACEUTICAL INC. | June 2, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 4 funds |
| BK Technologies Corporation | June 18, 2026 | To elect seven directors to serve one-year terms: Joshua S. Horowitz Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| BKV Corp. | June 11, 2026 | Election of Class II Directors: Carla Mashinski Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| BKV Corp. | June 11, 2026 | Election of Class II Directors: Sunit S. Patel Director Elections |
Board | For | FOR 6 funds |
WITHHOLD 1 fund |
| BLACKLINE, INC. | May 7, 2026 | Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 3 funds |
← Previous Page 2 of 57 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.